Scienion and Genomica expand collaboration to provide a new innovative printing technology for multiple applications.

08-Nov-2012 - Germany

Scienion AG and Genomica S.A. Unipersonal announced the expansion of their strategic partnership. Both companies will offer to the life science market a jointly developed new printing plate technology platform. This new platform combines Scienion's non-contact arraying and surface technologies with Genomica's multiplex PCR technology and microarrays detection. Both enterprises will advance in the development of new molecular applications, among which, in vitro diagnostics and personalized medicine will lead the way.

Dr. Holger Eickhoff, CEO of Scienion AG, stated: “The technologies of our companies optimally complement one another. Genomica has an excellent track record of successfully marketed DNA-based IVD tests and with its CLART® technology products the company is considered a benchmark in molecular diagnostics. Combining this expertise with Scienion’s state of the art non-contact dispensing technology, our consumables such as high quality microtiter plates and our production capabilities adds up to a perfect match. We are aiming to speed up the development of better and safer in vitro diagnostics and will offer joint technology solutions for the benefit of users and last but not least also for patients.”

Other news from the department business & finance

More news from our other portals

So close that even
molecules turn red...